LACK OF FUNCTIONAL SIMILARITY BETWEEN COMPLEMENT FACTOR-H AND ANTICARDIOLIPIN COFACTOR, BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)

被引:9
|
作者
PUURUNEN, M [1 ]
JOKIRANTA, S [1 ]
VAARALA, O [1 ]
MERI, S [1 ]
机构
[1] UNIV HELSINKI,DEPT BACTERIOL & IMMUNOL,HELSINKI,FINLAND
关键词
D O I
10.1111/j.1365-3083.1995.tb03694.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Beta 2-glycoprotein I (beta 2-GPI) is a 50 kDa protein in human plasma composed of five repeating complement control protein modules thereby closely resembling complement factor H which has 20 such units. Both beta 2-GPI and factor H (150 kDa) have binding sites for negatively charged polyions. beta 2-GPI has been shown to act as a cofactor for antiphospholipid antibodies upon their binding to anionic phospholipids. In factor H the polyanion recognition site participates in the discrimination between alternative pathway activating and non-activating surfaces. In light of the structural similarity between beta 2-GPI and factor H we have examined whether beta 2-GPI has a role in the alternative complement pathway recognition process. Both activators (zymosan) and non-activators (sheep erythrocytes) of the alternative complement pathway were coated with C3b. Radiolabelled factor H was observed to recognize C3b on both surfaces, whereas beta 2-GPI bound to neither. In competition experiments beta 2-GPI could not prevent the association of I-125-H With either non-activator or activator bound C3b. Conversely, factor H could not replace beta 2-GPI as a cofactor for antiphospholipid antibodies upon their binding to anionic phospholipids. It is concluded that beta 2-GPI and factor H, despite similarities in structure, exhibit distinct, non-overlapping functions.
引用
收藏
页码:547 / 550
页数:4
相关论文
共 50 条
  • [1] ANTIPHOSPHOLIPID ANTIBODIES REQUIRE BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) AS COFACTOR
    JONES, JV
    JAMES, H
    TAN, MH
    MANSOUR, M
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (09) : 1397 - 1402
  • [2] BETA-2-GLYCOPROTEIN-I - MOLECULAR-PROPERTIES OF AN UNUSUAL APOLIPOPROTEIN, APOLIPOPROTEIN-H
    LEE, NS
    BREWER, HB
    OSBORNE, JC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (08) : 4765 - 4770
  • [3] ISOLATION AND CHARACTERIZATION OF THE PROTEIN AND CDNA FOR BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)
    DAY, J
    BERKAW, M
    ARNAUD, P
    PROTIDES OF THE BIOLOGICAL FLUIDS, VOL 36: LIPOPROTEINS, IGG AND IGA SUBCLASSES, CYTOFLUOROMETRY, 1989, 36 : 423 - 429
  • [4] EXCRETION OF BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) IN RENAL TUBULAR DISEASE
    NORDEN, AGW
    FULCHER, LM
    LAPSLEY, M
    FLYNN, FV
    CLINICAL CHEMISTRY, 1991, 37 (01) : 74 - 77
  • [5] BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) INTERACTIONS WITH PHOSPHOLIPID-VESICLES
    WURM, H
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1984, 16 (05): : 511 - 515
  • [6] CHARACTERIZATION AND ACUTE PHASE MODULATION OF CANINE APOLIPOPROTEIN-H (BETA-2-GLYCOPROTEIN-I)
    SELLAR, GC
    KEANE, J
    MEHDI, H
    PEEPLES, ME
    BROWNE, N
    WHITEHEAD, AS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) : 1288 - 1293
  • [7] CHARACTERIZATION OF PLASMA-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) DEFICIENCY
    HOEG, JM
    SEGAL, P
    GREGG, RE
    CHANG, YS
    LINDGREN, FT
    ADAMSON, GL
    FRANK, M
    BRICKMAN, C
    BREWER, HB
    ATHEROSCLEROSIS, 1985, 55 (01) : 25 - 34
  • [8] NUCLEOTIDE-SEQUENCE AND EXPRESSION OF THE HUMAN GENE ENCODING APOLIPOPROTEIN-H (BETA-2-GLYCOPROTEIN-I)
    MEHDI, H
    NUNN, M
    STEEL, DM
    WHITEHEAD, AS
    PEREZ, M
    WALKER, L
    PEEPLES, ME
    GENE, 1991, 108 (02) : 293 - 298
  • [9] APOLIPOPROTEIN H (BETA-2-GLYCOPROTEIN-I) POLYMORPHISM IN ASIANS
    SAHA, N
    KAMBOH, MI
    KELLY, LJ
    FERRELL, RE
    TAY, JSH
    HUMAN BIOLOGY, 1992, 64 (04) : 617 - 621
  • [10] HETEROGENEITY OF THE APOLIPOPROTEIN H-ASTERISK-3 ALLELE AND ITS ROLE IN AFFECTING THE BINDING OF APOLIPOPROTEIN-H (BETA-2-GLYCOPROTEIN-I) TO ANIONIC PHOSPHOLIPIDS
    KAMBOH, MI
    WAGENKNECHT, DR
    MCINTYRE, JA
    HUMAN GENETICS, 1995, 95 (04) : 385 - 388